PRINCIPAL FINANCIAL GROUP INC
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 1126328
DES MOINES, IA
Position in XERS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,801,150
+$591,810 QoQ
Shares Held
227,418
+9.1% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 238 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $549,104,897 across 28 Drug Manufacturers - Specialty & Generic names. XERS ranks #24 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COLL |
Collegium Pharmaceutical, Inc
|
1,632,360 | $59,091,431 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
1,667,073 | $57,797,420 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
106,561 | $57,737,945 | |
| 4 | ALKS |
Alkermes plc.
|
983,822 | $51,552,272 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
239,193 | $40,313,587 | |
| 6 | ZTS |
Zoetis Inc.
|
527,859 | $37,931,946 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
772,174 | $31,682,298 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
1,133,913 | $27,905,598 |
All Filings in XERS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,801,150 | 227,418 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $1,209,340 | 208,507 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $1,181,887 | 150,559 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $858,712 | 105,493 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $718,885 | 153,937 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $624,465 | 113,746 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $383,805 | 113,217 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $292,036 | 102,469 | Shares | Defined | 2024-12-19 | |
| 2024-06-30 | $176,907 | 78,626 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $198,055 | 89,618 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $105,103 | 44,725 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $80,210 | 43,124 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $118,659 | 45,290 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $24,392 | 14,965 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $21,272 | 15,994 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $134,233 | 86,048 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $271,235 | 176,127 | Shares | Defined | 2022-08-10 | |
| No filing history on record for this holder in this stock. | ||||||